Cargando…
Transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin, for patients with invasive bladder cancer – clinical outcome
AIM OF THE STUDY: To evaluate the toxicity, clinical effectiveness and survival rate of transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin in patients with muscle invasive bladder cancer. MATERIAL...
Autores principales: | Nowak-Sadzikowska, Jadwiga, Jakubowicz, Jerzy, Skóra, Tomasz, Pudełek, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934068/ https://www.ncbi.nlm.nih.gov/pubmed/24596519 http://dx.doi.org/10.5114/wo.2013.35276 |
Ejemplares similares
-
The Benefit of Zinc Sulfate in Oropharyngeal Mucositis during Hyperfractionated Accelerated Concomitant Boost Radiotherapy with Concurrent Cisplatin for Advanced-Stage Oropharyngeal and Hypopharyngeal Cancers
por: Anandhi, P, et al.
Publicado: (2020) -
Postoperative irradiation in patients with pT3-4N0 laryngeal cancer: results and prognostic factors
por: Skóra, Tomasz, et al.
Publicado: (2014) -
Preoperative short-course radiotherapy in rectal cancer patients: results and prognostic factors
por: Skóra, Tomasz, et al.
Publicado: (2017) -
Hyperfractionated Radiotherapy with Concurrent Cisplatin/5-Fluorouracil for Locoregional Advanced Head and Neck Cancer: Analysis of 105 Consecutive Patients
por: Zaboli, David, et al.
Publicado: (2012) -
Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study
por: Gural, Zeynep, et al.
Publicado: (2018)